— Know what they know.
Not Investment Advice

INVA NASDAQ

Innoviva, Inc.
1W: -1.6% 1M: -1.4% 3M: -3.2% YTD: +5.4% 1Y: +18.2% 3Y: +63.1% 5Y: +27.6%
$20.94
-0.11 (-0.52%)
Pre-Market: $21.21 (+0.27, +1.29%)
Weekly Expected Move ±3.5%
$19 $20 $21 $21 $22
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $1.5B mcap · 68M float · 1.19% daily turnover · Short 42% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 15.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.21 (down 99%), Innoviva, Inc. would be worth roughly what it owes.
Total debt $269.7M against a stock market value of $1.51B.
Distance to default 10.31 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $129.2M (short-term plus half of long-term), stock volatility 26.8%; Altman Z'' 9.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$1.6B +25.7% ▲
5Y CAGR: +10.3%
Total Liabilities
$462M -24.2% ▼
5Y CAGR: +3.4%
Shareholders Equity
$1.2B +69.7% ▲
5Y CAGR: +16.8%
Cash & Investments
$551M +33.6% ▲
5Y CAGR: +17.5%
Total Debt
$269M -40.4% ▼
5Y CAGR: -6.9%
Net Debt
-$282M -292.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$202M$291M$194M$305M$551M
Short-Term Investments$0$0$0$108M$0
Cash & ST Investments$202M$291M$194M$412M$551M
Net Receivables$111M$64M$84M$86M$35M
Inventory$0$56M$41M$34M$39M
Other Current Assets$70K$3M$4M$656K$102M
Total Current Assets$314M$444M$344M$554M$728M
Property, Plant & Equip.$109K$3M$3M$3M$12M
Goodwill & Intangibles$0$280M$248M$226M$200M
Long-Term Investments$484M$403M$561M$394M$194M
Other Non-Current Assets$129M$102M$87M$111M$501M
Total Non-Current Assets$613M$788M$899M$747M$908M
Total Assets$926M$1.2B$1.2B$1.3B$1.6B
— Liabilities —
Accounts Payable$27K$3M$7M$2M$5M
Short-Term Debt$0$96M$0$192M$418K
Deferred Revenue$0$2M$1M$1M$4M
Other Current Liabilities$0$3M$0$6M$40M
Total Current Liabilities$6M$135M$38M$236M$50M
Long-Term Debt$395M$444M$446M$256M$258M
Other Non-Current Liab.$1$78M$82M$116M$112M
Total Non-Current Liabilities$395M$531M$530M$374M$413M
Total Liabilities$400M$666M$569M$610M$462M
— Equity —
Common Stock$696K$692K$633K$627K$747K
Retained Earnings-$456M-$205M-$25M-$2M$269M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$415M$566M$675M$691M$1.2B
Total Liabilities & Equity$926M$1.2B$1.2B$1.3B$1.6B
— Key Metrics —
Total Debt$395M$544M$449M$451M$269M
Net Debt$193M$253M$256M$146M-$282M
Total Investments$484M$403M$561M$501M$194M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms